In-depth immunophenotyping data relating to IL-17Ab modulation of circulating Treg/Th17 cells and of in situ infiltrated inflammatory monocytes in the onset of gouty inflammation The data supplied in this work are related to the research article entitled "IL-17A neutralizing antibody regulates monosodium urate crystal-induced gouty inflammation" [1] . This data article presents the results of the gating strategy applied to identify Treg population in peripheral blood of mice injected with MSU crystals and MSU crystals þ interleukin-17 antibody (IL-17Ab). Lastly, this article provides in-depth immunophenotyping data relating to all specific and isotype control antibodies used in the phenotypical characterization of circulating
Data
Our data indicate a correlation between the administration of IL-17 neutralizing antibody (IL-17Ab) and a reduction in circulating Th17 cells (defined as CD4 þ IL-17 þ ) and in situ infiltrated inflammatory monocytes (defined as B220
However, administration of IL-17Ab did not interfere with circulating Treg levels (defines as CD4
. The methodology for the determination of these cell subsets is based on a standardized flow cytometry gating strategy and data analysis of related isotype control antibodies. The data presented here contribute to the understanding of the real percentage of Th17 cells and inflammatory monocytes presented in our recent published paper [1] .
In particular, to identify the systemic Treg and Th17 balance, we stained isolated peripheral lymphocytes cells with an anti-CD4, an accessory protein for MHC class-II antigen/T-cell receptor interaction, an anti-CD8, a marker that identifies cytotoxic/suppressor T-cells that interacts with MHC class I. We also stained isolated peripheral lymphocytes with an anti-CD4/IL-17 and anti-CD4/CD25/Foxp3 to identify Th17 and Treg population respectively.
For Treg, we first established the gate for cells that were positive for CD4 and then gated for CD25 and Foxp3 (Fig. 1) . Dot plots values indicate the percentage of positively stained cells in the different experimental conditions and are presented as means ± SD of n ¼ 6 mice per group (Table 1) .
These values were strengthened by low percentage of positive cells found in all the staining for the related isotype control antibodies (Fig. 2) . Data are presented as means ± SD of n ¼ 6 mice per group (Table 2) .
Finally, we also report the percentage of positive cells found in all the staining for the isotype control antibodies related to B220
high CD115 þ cells (Fig. 3 ). Data are presented as means ± SD of n ¼ 6 mice per group (Table 3) . 
Experimental design, materials, and methods
CD-1 male mice (Charles River, Italy) weighing 25e30 g were used in all the experiments. Mice were housed in colony cages (six mice per cage) under standard conditions of light, temperature, and relative humidity for at least one week before the start of experimental procedures. Food and water were available ad libitum. All experiments were performed according to Legislative Decree 26/14, which implements the European Directive 2010/63/UE on laboratory animal protection in Italy, and were approved by the local Ethics Committee. According to the protocol described by Akitsu and colleagues [2] ankle joints of CD-1 mice were removed and digested with hyaluronidase (2.4 mg ml À1 ) and collagenase (1 mg ml À1 ) in RPMI 1640 plus 10% FBS for 1 h at 37 C after the induction of experimental analysis were performed by using one-way ANOVA followed by Bonferroni or Dunnett's post-test, when comparing more than two groups. GraphPad Prism 7.0 software (San Diego, CA, USA) was used for analysis. Data were considered statistically significant when a value of P 0.05 was achieved. 
